- Investing Ideas
- Hong Kong Healthcare Undervalued based on future growth
Hong Kong Healthcare Undervalued based on future growth
Results
6
Companies which can be considered undervalued when accounting for expected future growth (PEG under 0.8)
6 companies
Sinopharm Group
Market Cap: HK$54.2b
Engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People’s Republic of China.
1099
HK$17.38
7D
3.2%
1Y
-7.7%
Beijing Chunlizhengda Medical Instruments
Market Cap: HK$5.6b
Engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People’s Republic of China and internationally.
1858
HK$9.10
7D
5.1%
1Y
-39.1%
LEPU ScienTech Medical Technology (Shanghai)
Market Cap: HK$4.1b
An investment holding company, engages in the manufacture and sale of interventional treatment series occluders and heart valve medical devices.
2291
HK$11.92
7D
-17.8%
1Y
-53.1%
Chaoju Eye Care Holdings
Market Cap: HK$1.8b
Owns and operates a network of ophthalmic hospitals and centers in the People’s Republic of China.
2219
HK$2.64
7D
1.1%
1Y
-10.8%
Yonghe Medical Group
Market Cap: HK$1.2b
Provides hair-related healthcare services in China.
2279
HK$2.44
7D
13.0%
1Y
-12.2%
Sisram Medical
Market Cap: HK$1.2b
Engages in the research, design, development, manufacture, sale, and marketing of medical aesthetics and dental equipment, home-use devices, injectables, and cosmeceutical products in the Asia Pacific, North America, Europe, the Middle East, Africa, and Latin America.
1696
HK$2.53
7D
-2.3%
1Y
-56.1%